RSV and COVID-19 trigger different immune responses in infants
View as a Web Page
News Medical
 
  Pulmonology Pulmonology logo  
  The latest pulmonology news from News Medical  
 New antimicrobial strategies show how science is tackling rising drug resistanceNew antimicrobial strategies show how science is tackling rising drug resistance
 
This narrative review in the British Journal of Biomedical Science examines emerging and recently approved therapeutic strategies to combat antimicrobial resistance, spanning new antibiotics, microbiome interventions, natural products, predatory bacteria, vaccines, and advanced technologies. It highlights both promising innovations and the urgent need for sustained global investment as many approaches remain in early development.
 
 
 RSV and COVID-19 trigger different immune responses in infantsRSV and COVID-19 trigger different immune responses in infants
 
Young infants hospitalized with respiratory syncytial virus (RSV) often become much sicker compared to those infected with SARS-CoV-2, the virus that causes COVID-19.
 
   New method isolates true transcription factor targets in tuberculosis bacteriaNew method isolates true transcription factor targets in tuberculosis bacteria
 
Inside every cell, thousands of molecular signals collide, overlap, and compensate, obscuring the true drivers of gene expression.
 
   COVID-19 initially reduced asthma attacks but widened socioeconomic disparities, study findsCOVID-19 initially reduced asthma attacks but widened socioeconomic disparities, study finds
 
A large retrospective study of more than 162,000 asthma patients in the Bronx found that asthma exacerbations dropped sharply after the onset of COVID-19 before rebounding in children but remaining lower in adults.
 
   Sustainable inhalers offer better outcomes for COPD patientsSustainable inhalers offer better outcomes for COPD patients
 
New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly better patient outcomes.
 
 Experimental antibiotics disrupt bacterium that causes tuberculosis
 
Researchers from the University of Sydney and the Centenary Institute have discovered how a promising class of experimental antibiotics disrupts the bacterium that causes tuberculosis (TB), paving the way for urgently needed new treatments.
 
 
 Untreated sleep apnea may cost the UK and US billions annually
 
Untreated obstructive sleep apnea may be costing the UK and US economies billions of pounds/dollars in lost productivity every year, with a considerable proportion of working age adults experiencing symptoms indicative of the breathing disorder, suggests an analysis published online in the journal Thorax.
 
 
 Study identifies a promising strategy to treat brain metastases
 
A new study from researchers at Wake Forest University School of Medicine has identified a promising strategy to treat brain metastases, one of the most challenging and deadly complications of lung cancer.
 
 
 Blocking growth hormone receptor may improve treatment response in lung cancer
 
Blocking growth hormone receptor may improve treatment response in lung cancerResearchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments.
 
 
 Study highlights systemic forces sustaining tuberculosis transmission
 
Study highlights systemic forces sustaining tuberculosis transmissionDespite major advances in diagnostics and treatment, tuberculosis (TB) remains the world's deadliest infectious disease.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026